|
Video: What is a Stock Split?
|
|
Sonoma Pharmaceuticals is a global healthcare provider for developing and producing stabilized hypochlorous acid products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. Co.'s products include: Celacyn® Scar Management Gel, which provides scar management by protecting and moisturizing wound and scar sites; Microcyn® Wound Care Management, which provides enhanced healing properties; Acuicyn Eyelid and Eyelash Hygiene, which provides eyelid and eyelash hygiene; and Microdacyn60® Oral Care, which supports the treatment of mouth and throat infections and the debridement and moistening of mouth lesions and thrush. According to our Sonoma Pharmaceuticals stock split history records, Sonoma Pharmaceuticals has had 1 split. | |
|
Sonoma Pharmaceuticals (SNOA) has 1 split in our Sonoma Pharmaceuticals stock split history database. The split for SNOA took place on June 20, 2019. This was a 1 for 9 reverse split, meaning for each 9 shares of SNOA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 111.111111111111 share position following the split.
When a company such as Sonoma Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Sonoma Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 111.111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sonoma Pharmaceuticals shares, starting with a $10,000 purchase of SNOA, presented on a split-history-adjusted basis factoring in the complete Sonoma Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$36.36 |
|
End price/share: |
$0.17 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.53% |
|
Average Annual Total Return: |
-41.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$46.77 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
06/20/2019 | 1 for 9 |
|
|